輸入代號或公司名稱後按 Enter
4147

中裕

-1.80 (-2.92%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
59.80826成交張數本益比4.40股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.27-0.51-0.73-46.7%-1.95%-3.66%
2026Q10.06-0.460.169.8%0.43%-3.22%
2025Q4-0.25-0.61-0.69-45.7%-1.76%-4.26%
2025Q3-0.05-0.80-0.14-9.5%-0.36%-5.45%
2025Q2-0.22-0.89-0.59-43.2%-1.50%-6.00%
2025Q1-0.09-0.78-0.26-14.6%-0.64%-5.15%
2024Q4-0.44-0.75-1.20-82.7%-2.95%-6.13%
2024Q3-0.14-0.56-0.38-27.3%-0.91%-4.17%
2024Q2-0.11-0.44-0.28-18.7%-0.66%-3.21%
2024Q1-0.06-0.52-0.16-9.0%-0.47%-3.79%
2023Q4-0.25-0.77-0.60-38.1%-2.31%-7.38%
2023Q3-0.02-0.67-0.06-3.7%-0.22%-6.39%
2023Q2-0.19-0.80-0.48-45.9%-1.81%-7.48%
2023Q1-0.31-0.90-0.81-112.6%-3.02%-8.41%
2022Q4-0.15-1.05-0.38-11.6%-1.38%-9.52%
2022Q3-0.15-2.07-0.36-37.3%-1.30%-17.66%
2022Q2-0.29-2.23-0.76-76.3%-2.70%-18.76%
2022Q1-0.46-2455.6%-2.32-1.20-294.5%-4.15%-19.02%
2021Q4-1.17-1.84-2.99-393.8%-9.64%-14.82%
2021Q3-0.30-1.03-0.78-85.5%-2.36%-7.80%
2021Q2-0.38-424.9%-0.90-0.99-64.0%-2.94%-6.76%
2021Q10.02-0.400.055.4%0.14%-2.97%
2020Q4-0.36-0.72-0.92-60.3%-2.65%-5.24%
2020Q3-0.18-0.68-0.47-30.6%-1.32%-4.83%
2020Q20.12-1.760.3017.0%0.86%-11.93%
2020Q1-0.29-2.20-0.75-31.5%-2.12%-14.88%
2019Q4-0.32-2.26-0.82-39.1%-2.25%-15.09%
2019Q3-1.26-2.53-3.23-152.4%-8.45%-16.52%
2019Q2-0.32-237.4%-2.67-0.84-53.8%-2.08%-16.05%
2019Q1-0.35-170.6%-2.11-0.90-70.5%-2.22%-12.73%
2018Q4-0.60-1.26-1.53-133.2%-3.70%-7.68%
2018Q3-1.40-1.32-3.57-407.2%-8.16%-7.73%
2018Q20.24-0.330.61158.8%1.36%-1.82%
2018Q10.50-1.251.272.92%-6.95%
2017Q4-0.66-2.06-1.67-6925.5%-3.81%-11.65%
2017Q3-0.41-1.84-1.05-4346.0%-2.32%-10.06%
2017Q2-0.68-1.61-1.72-7152.0%-3.72%-8.73%
2017Q1-0.31-1.21-0.81-6673.2%-1.73%-6.44%
2016Q4-0.43-1.12-1.08-17329.4%-2.27%
2016Q3-0.19-0.49-7816.5%-1.01%